| Number | GOID | Name | p-value | FDR(GOSSIP) |
FWER(GOSSIP) | Holm | Sidak | BH | BY | Bonferoni |
| 1 | 278 | mitotic cell cycle | 2e-09 | 6.5e-07 | 3.1e-07 | 9.2e-07 | 9.2e-07 | 3.9e-07 | 2.7e-06 | 9.2e-07 |
| 2 | 7067 | mitosis | 2.1e-09 | 6.5e-07 | 3.3e-07 | 9.7e-07 | 9.7e-07 | 3.9e-07 | 2.7e-06 | 9.7e-07 |
| 3 | 87 | M phase of mitotic cell cycle | 2.5e-09 | 7.6e-07 | 5.7e-07 | 1.2e-06 | 1.2e-06 | 3.9e-07 | 2.7e-06 | 1.2e-06 |
| 4 | 15630 | microtubule cytoskeleton | 1.6e-08 | 2.4e-06 | 2.9e-06 | 7.2e-06 | 7.2e-06 | 1.7e-06 | 1.1e-05 | 7.3e-06 |
| 5 | 7049 | cell cycle | 2.1e-08 | 2.4e-06 | 3.7e-06 | 9.9e-06 | 9.9e-06 | 1.7e-06 | 1.1e-05 | 9.9e-06 |
| 6 | 280 | nuclear division | 2.2e-08 | 2.4e-06 | 3.7e-06 | 1e-05 | 1e-05 | 1.7e-06 | 1.1e-05 | 1e-05 |
| 7 | 279 | M phase | 3.8e-08 | 3.9e-06 | 6.8e-06 | 1.8e-05 | 1.8e-05 | 2.6e-06 | 1.7e-05 | 1.8e-05 |
| 8 | 5819 | spindle | 2.1e-07 | 1.6e-05 | 3.2e-05 | 9.5e-05 | 9.5e-05 | 1.2e-05 | 8.1e-05 | 9.6e-05 |
| 9 | 74 | regulation of cell cycle | 9.9e-07 | 7.9e-05 | 0.00018 | 0.00046 | 0.00046 | 5.2e-05 | 0.00035 | 0.00046 |
| 10 | 8283 | cell proliferation | 1.2e-06 | 8.5e-05 | 0.00021 | 0.00055 | 0.00055 | 5.6e-05 | 0.00038 | 0.00056 |
| 11 | 775 | chromosome, pericentric region | 9.8e-05 | 0.0092 | 0.025 | 0.045 | 0.044 | 0.0042 | 0.028 | 0.046 |
| 12 | 7088 | regulation of mitosis | 0.00014 | 0.01 | 0.03 | 0.062 | 0.06 | 0.0053 | 0.036 | 0.063 |
| 13 | 8301 | DNA bending activity | 0.00028 | 0.028 | 0.086 | 0.13 | 0.12 | 0.01 | 0.069 | 0.13 |
| 14 | 9987 | cellular process | 0.00035 | 0.029 | 0.096 | 0.16 | 0.15 | 0.012 | 0.079 | 0.16 |
| 15 | 910 | cytokinesis | 0.0004 | 0.029 | 0.1 | 0.18 | 0.17 | 0.012 | 0.084 | 0.19 |
| 16 | 5634 | nucleus | 0.00063 | 0.039 | 0.15 | 0.28 | 0.25 | 0.018 | 0.12 | 0.29 |
| 17 | 5856 | cytoskeleton | 0.00066 | 0.039 | 0.15 | 0.3 | 0.26 | 0.018 | 0.12 | 0.31 |
| 18 | 86 | G2/M transition of mitotic cell cycle | 0.0011 | 0.064 | 0.25 | 0.49 | 0.38 | 0.028 | 0.19 | 0.5 |
| 19 | 5694 | chromosome | 0.0016 | 0.08 | 0.32 | 0.72 | 0.51 | 0.039 | 0.27 | 0.75 |
| 20 | 5680 | anaphase-promoting complex | 0.0021 | 0.098 | 0.41 | 0.93 | 0.61 | 0.045 | 0.31 | 0.97 |
| 21 | 152 | nuclear ubiquitin ligase complex | 0.0021 | 0.098 | 0.41 | 0.93 | 0.61 | 0.045 | 0.31 | 0.97 |
| 22 | 5874 | microtubule | 0.0021 | 0.098 | 0.42 | 0.95 | 0.62 | 0.045 | 0.31 | 1 |
| 23 | 3773 | heat shock protein activity | 0.0025 | 0.099 | 0.44 | 1 | 0.67 | 0.051 | 0.34 | 1 |
| 24 | 5813 | centrosome | 0.0029 | 0.11 | 0.48 | 1 | 0.72 | 0.056 | 0.38 | 1 |
| 25 | 7050 | cell cycle arrest | 0.0034 | 0.12 | 0.53 | 1 | 0.78 | 0.064 | 0.43 | 1 |
| 26 | 922 | spindle pole | 0.004 | 0.13 | 0.58 | 1 | 0.83 | 0.07 | 0.47 | 1 |
| 27 | 8151 | cell growth and/or maintenance | 0.004 | 0.13 | 0.58 | 1 | 0.83 | 0.07 | 0.47 | 1 |
| 28 | 5815 | microtubule organizing center | 0.0045 | 0.14 | 0.62 | 1 | 0.86 | 0.075 | 0.51 | 1 |
| 29 | 4857 | enzyme inhibitor activity | 0.0061 | 0.16 | 0.7 | 1 | 0.93 | 0.093 | 0.63 | 1 |
| 30 | 5871 | kinesin complex | 0.0061 | 0.16 | 0.72 | 1 | 0.93 | 0.093 | 0.63 | 1 |
| 31 | 5622 | intracellular | 0.0062 | 0.16 | 0.72 | 1 | 0.93 | 0.093 | 0.63 | 1 |
| 32 | 19835 | cytolysis | 0.0068 | 0.17 | 0.75 | 1 | 0.95 | 0.099 | 0.66 | 1 |
| 33 | 797 | condensin core heterodimer | 0.0069 | 0.38 | 0.96 | 1 | 0.95 | 0.099 | 0.66 | 1 |
| 34 | 79 | regulation of CDK activity | 0.0076 | 0.38 | 0.96 | 1 | 0.96 | 0.11 | 0.71 | 1 |
| 35 | 4693 | cyclin-dependent protein kinase activity | 0.0084 | 0.38 | 0.97 | 1 | 0.97 | 0.11 | 0.75 | 1 |
| 36 | 8189 | apoptosis inhibitor activity | 0.0096 | 0.4 | 0.97 | 1 | 0.98 | 0.12 | 0.84 | 1 |
| 37 | 3754 | chaperone activity | 0.012 | 0.42 | 0.98 | 1 | 0.99 | 0.15 | 0.99 | 1 |
| 38 | 19212 | phosphatase inhibitor activity | 0.012 | 0.42 | 0.98 | 1 | 0.99 | 0.15 | 0.99 | 1 |
| 39 | 19237 | centromeric DNA binding | 0.014 | 0.61 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 40 | 796 | condensin complex | 0.014 | 0.61 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 41 | 3865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity | 0.014 | 0.61 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 42 | 16649 | oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor | 0.014 | 0.61 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 43 | 4174 | electron-transferring-flavoprotein dehydrogenase activity | 0.014 | 0.61 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 44 | 776 | kinetochore | 0.02 | 0.66 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 45 | 4860 | protein kinase inhibitor activity | 0.02 | 0.66 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 46 | 47238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 47 | 47237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 48 | 85 | G2 phase of mitotic cell cycle | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 49 | 42393 | histone binding | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 50 | 6977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 51 | 8571 | non-chaperonin molecular chaperone ATPase activity | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 52 | 17147 | Wnt-protein binding | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 53 | 5098 | Ran GTPase activator activity | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 54 | 5881 | cytoplasmic microtubule | 0.021 | 0.72 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 55 | 50790 | regulation of enzyme activity | 0.023 | 0.72 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 56 | 82 | G1/S transition of mitotic cell cycle | 0.023 | 0.72 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 57 | 19210 | kinase inhibitor activity | 0.025 | 0.72 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 58 | 5741 | mitochondrial outer membrane | 0.026 | 0.72 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 59 | 30234 | enzyme regulator activity | 0.026 | 0.72 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 60 | 6090 | pyruvate metabolism | 0.028 | 0.8 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 61 | 30330 | DNA damage response, signal transduction by p53 class mediator | 0.028 | 0.8 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 62 | 8426 | protein kinase C inhibitor activity | 0.028 | 0.8 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 63 | 6087 | pyruvate dehydrogenase bypass | 0.028 | 0.8 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 64 | 4791 | thioredoxin-disulfide reductase activity | 0.028 | 0.8 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 65 | 7091 | mitotic metaphase/anaphase transition | 0.028 | 0.8 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 66 | 50653 | chondroitin sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 67 | 4727 | prenylated protein tyrosine phosphatase activity | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 68 | 5579 | membrane attack complex | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 69 | 4749 | ribose-phosphate diphosphokinase activity | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 70 | 4473 | malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 71 | 5876 | spindle microtubule | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 72 | 45298 | tubulin | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 73 | 8095 | inositol-1,4,5-triphosphate receptor activity | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 74 | 3683 | lamin/chromatin binding | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 75 | 5220 | inositol 1,4,5-triphosphate-sensitive calcium-release channel activity | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 76 | 30178 | negative regulation of Wnt receptor signaling pathway | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 77 | 42267 | natural killer cell mediated cytolysis | 0.034 | 0.82 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 78 | 4725 | protein-tyrosine-phosphatase activity | 0.036 | 0.82 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 79 | 6512 | ubiquitin cycle | 0.037 | 0.82 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 80 | 8094 | DNA dependent ATPase activity | 0.041 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 81 | 46934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 0.041 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 82 | 16778 | diphosphotransferase activity | 0.041 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 83 | 30206 | chondroitin sulfate biosynthesis | 0.041 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 84 | 30204 | chondroitin sulfate metabolism | 0.041 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 85 | 4597 | peptide-aspartate beta-dioxygenase activity | 0.041 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 86 | 5875 | microtubule associated complex | 0.042 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 87 | 151 | ubiquitin ligase complex | 0.042 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 88 | 75 | cell cycle checkpoint | 0.044 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 89 | 43066 | negative regulation of apoptosis | 0.045 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 90 | 6916 | anti-apoptosis | 0.045 | 0.83 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 91 | 6108 | malate metabolism | 0.048 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 92 | 7126 | meiosis | 0.051 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 93 | 7017 | microtubule-based process | 0.051 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 94 | 30705 | cytoskeleton-dependent intracellular transport | 0.052 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 95 | 7018 | microtubule-based movement | 0.052 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 96 | 15278 | calcium-release channel activity | 0.054 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 97 | 4703 | G-protein coupled receptor kinase activity | 0.054 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 98 | 6067 | ethanol metabolism | 0.054 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 99 | 6069 | ethanol oxidation | 0.054 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 100 | 50650 | chondroitin sulfate proteoglycan biosynthesis | 0.054 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 101 | 16654 | oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor | 0.054 | 0.91 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 102 | 4674 | protein serine/threonine kinase activity | 0.057 | 0.91 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 103 | 3777 | microtubule motor activity | 0.058 | 0.91 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 104 | 50654 | chondroitin sulfate proteoglycan metabolism | 0.061 | 0.94 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 105 | 5521 | lamin binding | 0.061 | 0.94 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 106 | 88 | mitotic prophase | 0.061 | 0.94 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 107 | 4470 | malic enzyme activity | 0.061 | 0.94 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 108 | 7076 | mitotic chromosome condensation | 0.061 | 0.94 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 109 | 6913 | nucleocytoplasmic transport | 0.062 | 0.95 | 1 | 1 | 1 | 0.27 | 1 | 1 |
| 110 | 785 | chromatin | 0.065 | 0.95 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 111 | 5083 | small GTPase regulatory/interacting protein activity | 0.066 | 0.95 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 112 | 6081 | aldehyde metabolism | 0.067 | 0.98 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 113 | 3714 | transcription corepressor activity | 0.068 | 0.98 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 114 | 6464 | protein modification | 0.07 | 0.98 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 115 | 19888 | protein phosphatase regulator activity | 0.071 | 0.98 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 116 | 19867 | outer membrane | 0.071 | 0.98 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 117 | 3811 | complement activity | 0.074 | 1 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 118 | 4861 | cyclin-dependent protein kinase inhibitor activity | 0.074 | 1 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 119 | 7165 | signal transduction | 0.077 | 1 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 120 | 5524 | ATP binding | 0.079 | 1 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 121 | 19208 | phosphatase regulator activity | 0.079 | 1 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 122 | 7093 | mitotic checkpoint | 0.08 | 1 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 123 | 6024 | glycosaminoglycan biosynthesis | 0.08 | 1 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 124 | 7530 | sex determination | 0.08 | 1 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 125 | 4842 | ubiquitin-protein ligase activity | 0.084 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 126 | 19887 | protein kinase regulator activity | 0.085 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 127 | 30554 | adenyl nucleotide binding | 0.085 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 128 | 77 | DNA damage response, signal transduction resulting in cell cycle arrest | 0.087 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 129 | 5639 | integral to nuclear inner membrane | 0.087 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 130 | 16615 | malate dehydrogenase activity | 0.087 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 131 | 5217 | intracellular ligand-gated ion channel activity | 0.087 | 1 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 132 | 4672 | protein kinase activity | 0.089 | 1 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 133 | 16773 | phosphotransferase activity, alcohol group as acceptor | 0.09 | 1 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 134 | 7242 | intracellular signaling cascade | 0.092 | 1 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 135 | 15288 | porin activity | 0.093 | 1 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 136 | 19207 | kinase regulator activity | 0.096 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 137 | 3774 | motor activity | 0.096 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 138 | 6793 | phosphorus metabolism | 0.098 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 139 | 6796 | phosphate metabolism | 0.098 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 140 | 42288 | MHC class I protein binding | 0.099 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 141 | 4726 | non-membrane spanning protein tyrosine phosphatase activity | 0.099 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 142 | 6100 | TCA intermediate metabolism | 0.099 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 143 | 3677 | DNA binding | 0.1 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 144 | 6310 | DNA recombination | 0.1 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 145 | 16303 | phosphatidylinositol 3-kinase activity | 0.11 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 146 | 9618 | response to pathogenic bacteria | 0.11 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 147 | 6023 | aminoglycan biosynthesis | 0.11 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 148 | 35004 | phosphoinositide 3-kinase activity | 0.11 | 1 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 149 | 30166 | proteoglycan biosynthesis | 0.11 | 1 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 150 | 5942 | phosphoinositide 3-kinase complex | 0.12 | 1 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 151 | 42287 | MHC protein binding | 0.12 | 1 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 152 | 5637 | nuclear inner membrane | 0.12 | 1 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 153 | 19722 | calcium-mediated signaling | 0.12 | 1 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 154 | 8376 | acetylgalactosaminyltransferase activity | 0.12 | 1 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 155 | 16301 | kinase activity | 0.12 | 1 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 156 | 8091 | spectrin | 0.12 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 157 | 30863 | cortical cytoskeleton | 0.12 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 158 | 30864 | cortical actin cytoskeleton | 0.12 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 159 | 6626 | protein-mitochondrial targeting | 0.12 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 160 | 6605 | protein targeting | 0.13 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 161 | 122 | negative regulation of transcription from Pol II promoter | 0.13 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 162 | 6606 | protein-nucleus import | 0.13 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 163 | 8037 | cell recognition | 0.13 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 164 | 30693 | caspase activity | 0.13 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 165 | 30111 | regulation of Wnt receptor signaling pathway | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 166 | 793 | condensed chromosome | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 167 | 7548 | sex differentiation | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 168 | 16881 | acid-D-amino acid ligase activity | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 169 | 4840 | ubiquitin conjugating enzyme activity | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 170 | 16772 | transferase activity, transferring phosphorus-containing groups | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 171 | 7154 | cell communication | 0.14 | 1 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 172 | 8369 | obsolete molecular function | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 173 | 4721 | phosphoprotein phosphatase activity | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 174 | 17076 | purine nucleotide binding | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 175 | 6470 | protein amino acid dephosphorylation | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 176 | 9116 | nucleoside metabolism | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 177 | 6029 | proteoglycan metabolism | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 178 | 16311 | dephosphorylation | 0.14 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 179 | 8639 | small protein conjugating enzyme activity | 0.15 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 180 | 6270 | DNA replication initiation | 0.15 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 181 | 16637 | oxidoreductase activity, acting on the CH-CH group of donors, other acceptors | 0.15 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 182 | 5540 | hyaluronic acid binding | 0.15 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 183 | 30261 | chromosome condensation | 0.15 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 184 | 166 | nucleotide binding | 0.15 | 1 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 185 | 9617 | response to bacteria | 0.15 | 1 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 186 | 19200 | carbohydrate kinase activity | 0.15 | 1 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 187 | 4024 | alcohol dehydrogenase activity, zinc-dependent | 0.16 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 188 | 7205 | protein kinase C activation | 0.16 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 189 | 16645 | oxidoreductase activity, acting on the CH-NH group of donors | 0.16 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 190 | 19538 | protein metabolism | 0.16 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 191 | 45786 | negative regulation of cell cycle | 0.17 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 192 | 5938 | cell cortex | 0.17 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 193 | 4022 | alcohol dehydrogenase activity | 0.17 | 1 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 194 | 6468 | protein amino acid phosphorylation | 0.17 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 195 | 45893 | positive regulation of transcription, DNA-dependent | 0.17 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 196 | 16616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 197 | 30203 | glycosaminoglycan metabolism | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 198 | 6958 | complement activation, classical pathway | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 199 | 6406 | mRNA-nucleus export | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 200 | 4843 | ubiquitin-specific protease activity | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 201 | 8022 | protein C-terminus binding | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 202 | 42770 | DNA damage response, signal transduction | 0.18 | 1 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 203 | 8015 | circulation | 0.19 | 1 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 204 | 4 | biological_process unknown | 0.19 | 1 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 205 | 7218 | neuropeptide signaling pathway | 0.19 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 206 | 16614 | oxidoreductase activity, acting on CH-OH group of donors | 0.19 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 207 | 4869 | cysteine protease inhibitor activity | 0.19 | 1 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 208 | 45892 | negative regulation of transcription, DNA-dependent | 0.2 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 209 | 6357 | regulation of transcription from Pol II promoter | 0.2 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 210 | 6022 | aminoglycan metabolism | 0.2 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 211 | 30695 | GTPase regulator activity | 0.2 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 212 | 5085 | guanyl-nucleotide exchange factor activity | 0.21 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 213 | 16706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 0.21 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 214 | 7586 | digestion | 0.21 | 1 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 215 | 5635 | nuclear membrane | 0.21 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 216 | 6403 | RNA localization | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 217 | 6405 | RNA-nucleus export | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 218 | 50657 | nucleic acid transport | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 219 | 50658 | RNA transport | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 220 | 6956 | complement activation | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 221 | 5200 | structural constituent of cytoskeleton | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 222 | 16310 | phosphorylation | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 223 | 8150 | biological_process | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 224 | 1727 | lipid kinase activity | 0.22 | 1 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 225 | 16879 | ligase activity, forming carbon-nitrogen bonds | 0.22 | 1 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 226 | 16023 | cytoplasmic vesicle | 0.23 | 1 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 227 | 8277 | regulation of G-protein coupled receptor protein signaling pathway | 0.23 | 1 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 228 | 19904 | protein domain specific binding | 0.24 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 229 | 16209 | antioxidant activity | 0.24 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 230 | 5262 | calcium channel activity | 0.24 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 231 | 67 | DNA replication and chromosome cycle | 0.24 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 232 | 12505 | endomembrane system | 0.25 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 233 | 45941 | positive regulation of transcription | 0.25 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 234 | 4197 | cysteine-type endopeptidase activity | 0.25 | 1 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 235 | 3712 | transcription cofactor activity | 0.26 | 1 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 236 | 16791 | phosphoric monoester hydrolase activity | 0.26 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 237 | 398 | nuclear mRNA splicing, via spliceosome | 0.26 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 238 | 377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 0.26 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 239 | 375 | RNA splicing, via transesterification reactions | 0.26 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 240 | 8624 | induction of apoptosis by extracellular signals | 0.26 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 241 | 46907 | intracellular transport | 0.27 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 242 | 5048 | signal sequence binding | 0.27 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 243 | 16627 | oxidoreductase activity, acting on the CH-CH group of donors | 0.27 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 244 | 786 | nucleosome | 0.27 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 245 | 15036 | disulfide oxidoreductase activity | 0.27 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 246 | 15931 | nucleobase, nucleoside, nucleotide and nucleic acid transport | 0.27 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 247 | 5740 | mitochondrial membrane | 0.28 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 248 | 42981 | regulation of apoptosis | 0.28 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 249 | 50789 | regulation of biological process | 0.28 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 250 | 4428 | inositol/phosphatidylinositol kinase activity | 0.28 | 1 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 251 | 3684 | damaged DNA binding | 0.29 | 1 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 252 | 6816 | calcium ion transport | 0.29 | 1 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 253 | 8134 | transcription factor binding | 0.3 | 1 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 254 | 5554 | molecular_function unknown | 0.3 | 1 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 255 | 8219 | cell death | 0.31 | 1 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 256 | 16481 | negative regulation of transcription | 0.31 | 1 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 257 | 7259 | JAK-STAT cascade | 0.31 | 1 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 258 | 16265 | death | 0.31 | 1 | 1 | 1 | 1 | 0.57 | 1 | 1 |
| 259 | 7010 | cytoskeleton organization and biogenesis | 0.33 | 1 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 260 | 8234 | cysteine-type peptidase activity | 0.33 | 1 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 261 | 6457 | protein folding | 0.33 | 1 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 262 | 19992 | diacylglycerol binding | 0.33 | 1 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 263 | 6334 | nucleosome assembly | 0.34 | 1 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 264 | 6790 | sulfur metabolism | 0.34 | 1 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 265 | 7200 | G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | 0.35 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 266 | 6511 | ubiquitin-dependent protein catabolism | 0.35 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 267 | 19941 | modification-dependent protein catabolism | 0.35 | 1 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 268 | 3676 | nucleic acid binding | 0.35 | 1 | 1 | 1 | 1 | 0.62 | 1 | 1 |
| 269 | 3682 | chromatin binding | 0.37 | 1 | 1 | 1 | 1 | 0.64 | 1 | 1 |
| 270 | 5489 | electron transporter activity | 0.37 | 1 | 1 | 1 | 1 | 0.64 | 1 | 1 |
| 271 | 6350 | transcription | 0.37 | 1 | 1 | 1 | 1 | 0.64 | 1 | 1 |
| 272 | 5541 | acyl-CoA or acyl binding | 0.37 | 1 | 1 | 1 | 1 | 0.64 | 1 | 1 |
| 273 | 15276 | ligand-gated ion channel activity | 0.38 | 1 | 1 | 1 | 1 | 0.65 | 1 | 1 |
| 274 | 8076 | voltage-gated potassium channel complex | 0.4 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 275 | 5789 | endoplasmic reticulum membrane | 0.4 | 1 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 276 | 5261 | cation channel activity | 0.4 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 277 | 5737 | cytoplasm | 0.4 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 278 | 5575 | cellular_component | 0.4 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 279 | 7186 | G-protein coupled receptor protein signaling pathway | 0.4 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 280 | 42175 | nuclear envelope-endoplasmic reticulum network | 0.4 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 281 | 16651 | oxidoreductase activity, acting on NADH or NADPH | 0.41 | 1 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 282 | 8380 | RNA splicing | 0.42 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 283 | 42578 | phosphoric ester hydrolase activity | 0.42 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 284 | 46930 | pore complex | 0.42 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 285 | 5249 | voltage-gated potassium channel activity | 0.42 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 286 | 5643 | nuclear pore | 0.42 | 1 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 287 | 16051 | carbohydrate biosynthesis | 0.43 | 1 | 1 | 1 | 1 | 0.7 | 1 | 1 |
| 288 | 15267 | channel/pore class transporter activity | 0.43 | 1 | 1 | 1 | 1 | 0.7 | 1 | 1 |
| 289 | 5509 | calcium ion binding | 0.44 | 1 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 290 | 4221 | ubiquitin thiolesterase activity | 0.45 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 291 | 16874 | ligase activity | 0.45 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 292 | 5488 | binding | 0.45 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 293 | 6092 | main pathways of carbohydrate metabolism | 0.45 | 1 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 294 | 6397 | mRNA processing | 0.46 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 295 | 6355 | regulation of transcription, DNA-dependent | 0.46 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 296 | 15031 | protein transport | 0.46 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 297 | 5623 | cell | 0.46 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 298 | 7417 | central nervous system development | 0.47 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 299 | 16337 | cell-cell adhesion | 0.47 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 300 | 5539 | glycosaminoglycan binding | 0.47 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 301 | 6996 | organelle organization and biogenesis | 0.47 | 1 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 302 | 15674 | di-, tri-valent inorganic cation transport | 0.48 | 1 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 303 | 16071 | mRNA metabolism | 0.48 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 304 | 7157 | heterophilic cell adhesion | 0.49 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 305 | 16491 | oxidoreductase activity | 0.49 | 1 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 306 | 45449 | regulation of transcription | 0.5 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 307 | 5730 | nucleolus | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 308 | 19932 | second-messenger-mediated signaling | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 309 | 30528 | transcription regulator activity | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 310 | 16790 | thiolester hydrolase activity | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 311 | 3928 | RAB small monomeric GTPase activity | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 312 | 5625 | soluble fraction | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 313 | 6261 | DNA dependent DNA replication | 0.51 | 1 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 314 | 6351 | transcription, DNA-dependent | 0.52 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 315 | 6139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 0.52 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 316 | 5525 | GTP binding | 0.53 | 1 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 317 | 19001 | guanyl nucleotide binding | 0.53 | 1 | 1 | 1 | 1 | 0.79 | 1 | 1 |
| 318 | 7582 | physiological process | 0.54 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 319 | 1558 | regulation of cell growth | 0.54 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 320 | 7166 | cell surface receptor linked signal transduction | 0.54 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 321 | 7155 | cell adhesion | 0.55 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 322 | 6333 | chromatin assembly/disassembly | 0.55 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 323 | 5267 | potassium channel activity | 0.55 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 324 | 16705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.55 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 325 | 5911 | intercellular junction | 0.55 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 326 | 16055 | Wnt receptor signaling pathway | 0.56 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 327 | 9165 | nucleotide biosynthesis | 0.56 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 328 | 42277 | peptide binding | 0.56 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 329 | 46872 | metal ion binding | 0.56 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 330 | 16740 | transferase activity | 0.56 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 331 | 7028 | cytoplasm organization and biogenesis | 0.57 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 332 | 5529 | sugar binding | 0.57 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 333 | 16327 | apicolateral plasma membrane | 0.57 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 334 | 3702 | RNA polymerase II transcription factor activity | 0.57 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 335 | 50794 | regulation of cellular process | 0.58 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 336 | 4866 | endopeptidase inhibitor activity | 0.58 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 337 | 30054 | cell junction | 0.58 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 338 | 30246 | carbohydrate binding | 0.58 | 1 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 339 | 30414 | protease inhibitor activity | 0.58 | 1 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 340 | 1501 | skeletal development | 0.59 | 1 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 341 | 8372 | cellular_component unknown | 0.59 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 342 | 6974 | response to DNA damage stimulus | 0.6 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 343 | 5792 | microsome | 0.6 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 344 | 16064 | humoral defense mechanism (sensu Vertebrata) | 0.6 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 345 | 8284 | positive regulation of cell proliferation | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 346 | 6886 | intracellular protein transport | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 347 | 9719 | response to endogenous stimulus | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 348 | 16758 | transferase activity, transferring hexosyl groups | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 349 | 5576 | extracellular | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 350 | 6366 | transcription from Pol II promoter | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 351 | 42598 | vesicular fraction | 0.61 | 1 | 1 | 1 | 1 | 0.82 | 1 | 1 |
| 352 | 5194 | cell adhesion molecule activity | 0.63 | 1 | 1 | 1 | 1 | 0.83 | 1 | 1 |
| 353 | 5244 | voltage-gated ion channel activity | 0.63 | 1 | 1 | 1 | 1 | 0.83 | 1 | 1 |
| 354 | 5216 | ion channel activity | 0.63 | 1 | 1 | 1 | 1 | 0.83 | 1 | 1 |
| 355 | 7267 | cell-cell signaling | 0.64 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 356 | 15980 | energy derivation by oxidation of organic compounds | 0.64 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 357 | 6813 | potassium ion transport | 0.64 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 358 | 30001 | metal ion transport | 0.65 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 359 | 5578 | extracellular matrix | 0.65 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 360 | 16049 | cell growth | 0.65 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 361 | 16788 | hydrolase activity, acting on ester bonds | 0.65 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 362 | 42127 | regulation of cell proliferation | 0.65 | 1 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 363 | 5515 | protein binding | 0.66 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 364 | 6259 | DNA metabolism | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 365 | 43065 | positive regulation of apoptosis | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 366 | 43067 | regulation of programmed cell death | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 367 | 6917 | induction of apoptosis | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 368 | 43068 | positive regulation of programmed cell death | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 369 | 12502 | induction of programmed cell death | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 370 | 6915 | apoptosis | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 371 | 12501 | programmed cell death | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 372 | 15268 | alpha-type channel activity | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 373 | 3700 | transcription factor activity | 0.67 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 374 | 3729 | mRNA binding | 0.68 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 375 | 6959 | humoral immune response | 0.68 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 376 | 9117 | nucleotide metabolism | 0.68 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 377 | 8270 | zinc ion binding | 0.69 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 378 | 5096 | GTPase activator activity | 0.69 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 379 | 6928 | cell motility | 0.69 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 380 | 6508 | proteolysis and peptidolysis | 0.7 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 381 | 6954 | inflammatory response | 0.7 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 382 | 5516 | calmodulin binding | 0.7 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 383 | 8285 | negative regulation of cell proliferation | 0.7 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 384 | 5198 | structural molecule activity | 0.7 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 385 | 7264 | small GTPase mediated signal transduction | 0.7 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 386 | 42623 | ATPase activity, coupled | 0.71 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 387 | 45087 | innate immune response | 0.71 | 1 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 388 | 30163 | protein catabolism | 0.71 | 1 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 389 | 6260 | DNA replication | 0.72 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 390 | 84 | S phase of mitotic cell cycle | 0.73 | 1 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 391 | 8289 | lipid binding | 0.73 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 392 | 5840 | ribosome | 0.74 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 393 | 9057 | macromolecule catabolism | 0.74 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 394 | 16887 | ATPase activity | 0.74 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 395 | 16043 | cell organization and biogenesis | 0.75 | 1 | 1 | 1 | 1 | 0.88 | 1 | 1 |
| 396 | 3735 | structural constituent of ribosome | 0.76 | 1 | 1 | 1 | 1 | 0.9 | 1 | 1 |
| 397 | 16757 | transferase activity, transferring glycosyl groups | 0.77 | 1 | 1 | 1 | 1 | 0.91 | 1 | 1 |
| 398 | 3713 | transcription coactivator activity | 0.77 | 1 | 1 | 1 | 1 | 0.91 | 1 | 1 |
| 399 | 9613 | response to pest/pathogen/parasite | 0.78 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 400 | 6325 | establishment and/or maintenance of chromatin architecture | 0.79 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 401 | 16818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 402 | 7243 | protein kinase cascade | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 403 | 5975 | carbohydrate metabolism | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 404 | 3925 | small monomeric GTPase activity | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 405 | 7399 | neurogenesis | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 406 | 6281 | DNA repair | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 407 | 6323 | DNA packaging | 0.8 | 1 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 408 | 6066 | alcohol metabolism | 0.81 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 409 | 8233 | peptidase activity | 0.81 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 410 | 4930 | G-protein coupled receptor activity | 0.82 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 411 | 6091 | energy pathways | 0.82 | 1 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 412 | 46914 | transition metal ion binding | 0.83 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 413 | 6812 | cation transport | 0.83 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 414 | 9611 | response to wounding | 0.83 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 415 | 8047 | enzyme activator activity | 0.83 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 416 | 15629 | actin cytoskeleton | 0.83 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 417 | 6396 | RNA processing | 0.84 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 418 | 15672 | monovalent inorganic cation transport | 0.84 | 1 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 419 | 3779 | actin binding | 0.85 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 420 | 5739 | mitochondrion | 0.85 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 421 | 7001 | chromosome organization and biogenesis (sensu Eukarya) | 0.86 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 422 | 16070 | RNA metabolism | 0.86 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 423 | 5102 | receptor binding | 0.86 | 1 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 424 | 6997 | nuclear organization and biogenesis | 0.87 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 425 | 6950 | response to stress | 0.87 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 426 | 6810 | transport | 0.87 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 427 | 4872 | receptor activity | 0.87 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 428 | 267 | cell fraction | 0.88 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 429 | 3723 | RNA binding | 0.88 | 1 | 1 | 1 | 1 | 0.96 | 1 | 1 |
| 430 | 50800 | hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement | 0.89 | 1 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 431 | 5615 | extracellular space | 0.9 | 1 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 432 | 6952 | defense response | 0.9 | 1 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 433 | 8092 | cytoskeletal protein binding | 0.91 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 434 | 16817 | hydrolase activity, acting on acid anhydrides | 0.91 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 435 | 4713 | protein-tyrosine kinase activity | 0.91 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 436 | 9056 | catabolism | 0.91 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 437 | 8152 | metabolism | 0.92 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 438 | 5829 | cytosol | 0.92 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 439 | 3924 | GTPase activity | 0.92 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 440 | 9308 | amine metabolism | 0.92 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 441 | 6811 | ion transport | 0.93 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 442 | 30529 | ribonucleoprotein complex | 0.93 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 443 | 9607 | response to biotic stimulus | 0.93 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 444 | 6118 | electron transport | 0.93 | 1 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 445 | 4871 | signal transducer activity | 0.94 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 446 | 5624 | membrane fraction | 0.95 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 447 | 3824 | catalytic activity | 0.95 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 448 | 8565 | protein transporter activity | 0.95 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 449 | 6955 | immune response | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 450 | 5215 | transporter activity | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 451 | 4888 | transmembrane receptor activity | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 452 | 9887 | organogenesis | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 453 | 19752 | carboxylic acid metabolism | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 454 | 6082 | organic acid metabolism | 0.96 | 1 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 455 | 7275 | development | 0.97 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 456 | 5783 | endoplasmic reticulum | 0.97 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 457 | 9059 | macromolecule biosynthesis | 0.97 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 458 | 9653 | morphogenesis | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 459 | 3674 | molecular_function | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 460 | 16787 | hydrolase activity | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 461 | 6412 | protein biosynthesis | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 462 | 5887 | integral to plasma membrane | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 463 | 9058 | biosynthesis | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 464 | 16021 | integral to membrane | 0.99 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 465 | 9605 | response to external stimulus | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 466 | 5886 | plasma membrane | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 467 | 16020 | membrane | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 468 | 3673 | Gene_Ontology | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| | Number of significant terms | 91 | 17 | 12 | 11 | 11 | 22 | 12 | 11 |